Purpose: To evaluate the diagnostic performance of velocity-and acceleration-sensitized noncontrast-enhanced magnetic resonance angiography (NCE-MRA) of the infrageniculate arteries using contrast-enhanced MRA (CE-MRA) as a reference standard. Materials and Methods: Twenty-four patients with symptoms of peripheral arterial disease were recruited. Each patient's infrageniculate arterial tree was examined using a velocity-dependent flow-sensitized dephasing (VEL-FSD) technique, an acceleration-dependent (ACC-FSD) technique, and our conventional CE-MRA technique performed at 1.5T. The images were independently reviewed by two experienced vascular radiologists, who evaluated each vessel segment to assess visibility, diagnostic confidence, venous contamination, and detection of pathology.
P eripheral arterial disease (PAD) is a condition with increasing prevalence in the Western world that has a significant impact on individual patients in terms of morbidity and mortality and on the wider health community as a whole. 1 Treatment options include lifestyle and medical measures along with surgical and, increasingly, endovascular procedures. Diagnostic imaging plays an important role in directing management with duplex ultrasound (DUS), computed tomography angiography (CTA), and contrastenhanced magnetic resonance angiography (CE-MRA), all being well-established techniques. 2 These imaging modalities each have their own strengths and weaknesses. DUS has the advantage of being inexpensive and readily available. However, its effectiveness is reduced in obese patients and in the assessment of the supra-inguinal arteries, particularly in the presence of bowel gas. In addition, operator dependency remains an important limitation in its utility. CTA provides an excellent overview of the vascular system; however, it employs ionizing radiation and the relatively high prevalence of renal impairment 3 in this cohort of often elderly arteriopaths, and means that the use of intravascular contrast medium is often contraindicated. In addition, accurate assessment of the small vessels below the knee, which are often heavily calcified, may prove challenging with CTA. 4 CE-MRA avoids the limitations of reduced effectiveness in the supra-inguinal region and the use of ionizing radiation. However, the use of gadolinium-based agents in CE-MRA has been implicated in the development of nephrogenic systemic fibrosis (NSF) for patients with impaired renal function. 5 More recently, concerns have been raised regarding the accumulation of excess gadolinium within the brain. 6 Given the limitations of each of the conventionally employed imaging modalities, it is no surprise that in recent years attention has turned to the development of noncontrast-enhanced magnetic resonance angiography (NCE-MRA) for evaluation of the peripheral vasculature. In addition to negating concerns regarding NSF, NCE-MRA also avoids the issue of resolution limitations during firstpass acquisition. Additionally, it does not require careful timing of the acquisition relative to a bolus passage, and can bring increased flexibility; for example, allowing repeated acquisitions. Over time, original noncontrast techniques such as time of flight imaging have fallen out of favor for body imaging due to longer imaging times and concerns regarding image quality. 7 A number of newer techniques have been described that rely on intrinsic properties of flowing blood, such as relaxation times or flow characteristics. [8] [9] [10] [11] [12] [13] It is important that such methods are evaluated against existing techniques as a standard, with promising results already seen using a number of different techniques. [14] [15] [16] One recently developed NCE-MRA method uses a subtraction-based technique, combined with a controllable flow-dependent preparation module that suppresses the signal from flowing blood. 13, 17 A "dark blood" image is produced that can be subtracted from a nonflow-suppressed "bright blood" image to produce an image of the vasculature. By adjusting the strength of the motion sensitization gradients (MSG), the flow suppression can be adjusted such that visualization of the arteries, veins, or both is optimized. This technique is known either as flow-sensitized dephasing (FSD) or as vascular anatomy by nonenhanced static subtraction angiography (VANESSA), and has previously been used to visualize the infrageniculate vessels. 18 More recently, it has been demonstrated in healthy volunteers that the use of an acceleration-dependent flow-suppression module (then referred to as ADVANCE-MRA) rather than a velocitydependent flow-suppression module can improve arteriovenous separation, due to the intrinsic pulsatility of arterial flow. 19 The objective of this study was to compare the diagnostic and qualitative performance of the acceleration-and velocity-sensitized techniques in a population of patients with PAD, using our standard CE-MRA technique (timeresolved imaging of contrast kinetics: TRICKS) as a reference standard. In this work, the velocity-sensitized FSD method will be known as VEL-FSD and the accelerationsensitized method as ACC-FSD.
Materials and Methods
The study was approved by the local Ethical Committee and written informed consent was obtained from all patients. Twenty-four patients with symptoms of PAD were recruited following referral for routine CE-MRA.
Pulse Sequences and Scan Protocols
The MRI examinations were performed using a 1.5T MR system (Signa HDx, GE Healthcare, Waukesha, WI) with an 8-channel cardiac array coil. The two noncontrast methods under investigation were performed initially, followed by the routine CE-MRA. Scan triggering was performed using pulse oximetry. In order to locate the major leg arteries, an initial axial multislice 2D time of flight (TOF) acquisition was acquired, with the following scan parameters: echo time (TE) 1.4 msec; repetition time (TR) 4 ; slice thickness 5 mm; velocity encoding parameter [venc] 50-70 cm/s; retrospective gating with 100 reconstructed phases over the cardiac cycle). This was used to assess quickly the pulsatility of flow and the approximate time of peak arterial flow within the cardiac cycle (using the scanner's "FuncTool" software), in order to set the trigger delay for the subsequent NCE-MRA. If peak flow times varied between the two legs, the used setting aimed for the best compromise to aim for flow suppression in both legs if possible.
NCE-MRA was acquired using two subtraction-based methods, whose flow-preparation modules are shown in Fig. 1 -the velocity-dependent method VEL-FSD, which for this study used an iMSDE module 20 for flow suppression (Fig. 1a) , and the acceleration-dependent method ACC-FSD (Fig. 1b) . Note that these two flow-suppression modules differ mainly in the signs of the motion-sensitization gradients (MSG). Each NCE-MRA method used balanced steady-state free precession (bSSFP) for the imaging readout, with the following acquisition parameters: TE 1.6 msec, TR 3.5 msec, flip angle 658, acquisition matrix 256 3 224 3 28, FOV 33.3 3 30.0 cm, slice thickness 2.4 mm, oblique coronal orientation. For each 3D NCE-MRA sequence, scan time was 60 beats per volume, or 300 beats for the 5 volumes acquired. This corresponds to 5 minutes at a heart rate of 60 bpm.
Parallel imaging (regularized ASSET) was used with an acceleration factor of 2. The reconstructed resolution was increased by a factor of 2 in all three directions using zero-fill interpolation. Fatsaturation was applied twice: before the flow-preparation modules, to avoid stripes in the flow-suppressed image 17 ; and before the image readout, to reduce the fat signal in the images. For flow-suppression, the ACC-FSD acquisition used an acceleration-preparation module with an effective echo time (TE eff ) of 50 msec. In addition to a bright-blood image, four dark-artery images were acquired using MSG with duration 8 msec and amplitudes 0. respectively. 19 For both bright-and dark-blood images, the flowsensitization module was placed at the time of peak arterial flow as determined from the phase-contrast measurements, in late systole.
Following the flow-suppression module, there was a delay of 200 msec before the readout. This delay was added to place the readout in the diastolic portion of the cardiac cycle and thus avoid the reductions in vascular image quality that can occur due to rapid inflow into the image volume during the readout, 18 and its duration was chosen based on typical flow profiles seen in volunteers and previous patients during initial testing. For this dataset, the five image volumes were acquired consecutively in a single acquisition with automatic adjustment of the MSG amplitudes, and the only protocol adjustments needed from the operator were to define the image geometry and the time of peak flow. The VEL-FSD acquisition used an iMSDE module with TE eff 30 msec. One bright-blood and four dark-blood images were collected using an MSG with duration 3.4 msec and amplitudes of 0.5, 1.0, 2.0, and 15.0 mT/m. This corresponded to velocityencoding parameters (venc) of 23.0, 11.5, 5.76, and 0.768 cm/s, respectively. The final 15.0 mT/m acquisition gave images showing both arteries and veins. For the dark-blood images, the flowsensitization (iMSDE) module was placed at peak arterial flow, but for the bright-blood image a delay of 300 msec was added to place it in diastole. There was no additional delay between flowsensitization module and the readout. As above, the five image volumes were acquired consecutively in a single acquisition, with the operator defining only the image geometry and the time of peak flow.
The NCE-MRA acquisitions were followed by our standard clinical CE-MRA protocol using TRICKS, with the following scan parameters: TE/TR 2.8/8.3 msec; flip angle 458; FOV 44 3 30 cm 2 ; acquired matrix 512 3 156 3 28; slice thickness 2.4 mm. This gives an acquired spatial resolution of 0.86 3 1.92 3 2.40 mm 3 . The total scan time for a mask phase and 10 dynamic phases was 170 seconds, with a temporal resolution of 10.5 seconds and a temporal footprint of 63 seconds. A dose of 10 ml gadobutrol (Gadovist, Schering, Berlin, Germany) was given, followed by a 20-ml saline flush, at a rate of 0.5 ml/second. The orientation, thickness and (approximate) position of the imaging slices were matched for the CE-and NCE-sequences.
Assessment
To remove the edge regions most commonly affected by signal loss due to magnetic field inhomogeneity, the NCE-MRA images were cropped by 30 pixels in the S and I directions, giving a final S/I FOV of 29.4 cm. The CE-MRA images were then cropped in the S and I directions to a precisely matched FOV, to ensure that the same regions were compared in the subsequent comparisons. The images were then assessed independently by two vascular radiologists with 8 and 4 years experience, respectively (T.C.S. and A.P.W.). For both the CE-MRA and the NCE-MRA datasets, multiple phases/image volumes were available for assessment and reviewer was able to choose the "best" phase for assessment. Overall, 432 segments were evaluated for each of the three techniques by each of the two reviewers. The reviewers were blinded to patient identity and the examinations were reviewed in a semirandomized order, with care taken to ensure that the datasets for any given patient were not assessed in close temporal proximity. For analysis purposes the data from each reviewer were treated as separate data points, given that the purpose of the study was to compare the two noncontrast techniques with CE-MRA as the reference standard.
Both maximum intensity projections (MIPs) and individual slices were available for assessment. The below-knee arterial station was divided into nine segments: the proximal and distal belowknee popliteal (Pop), the tibio-peroneal trunk (TPT), the proximal and distal anterior tibial (AT), proximal and distal peroneal artery, and the proximal and distal posterior tibial (PT) arteries. To ensure equivalence between the two readers, the boundary between proximal and distal segments of vessels was defined as the midpoint of the vessel length assuming it continued to the edge of the field of view (ie, inferiorly for the AT, peroneal and PT, and superiorly for the popliteal artery). For each of the three techniques, each vessel segment was assessed in three separate ways. First, the vessel visibility was assessed as either visible (y), not visible (n), or partially visible (p). For partially or not visible segments, it was judged whether this related to pathology or to the imaging technique. This was left to the discretion of the expert reader, although as a guide it was suggested that signal loss that either affected the edges of the image, with good signal in other arteries, or which affected a wide central region, was deemed as "technique-related" if no collateral vessels were present to suggest disease. Then, diagnostic confidence was assessed on a four-point Likert scale (nondiagnostic, low confidence, moderate confidence, and high confidence). Finally, the venous contamination was assessed on a three-point scale: none (0); some, but not affecting diagnosis (1); and significant, affecting diagnosis (2).
Diagnostic confidence was then differentiated into moderate or high confidence versus low confidence or nondiagnostic for analysis purposes. Each segment was also assessed for pathology in terms of being normal, stenosis <50%, stenosis >50%, or occlusion. From the disease evaluation, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for detection of significant stenosis (>50%) were evaluated, considering CE-MRA as the reference standard. Nonevaluable segments on NCE-MRA that were visible on TRICKS were counted as "misses" for the purposes of evaluating sensitivity. In order to detect a difference in sensitivity between the two tests under consideration, the McNemar chi-squared test was used. This was calculated on a per-segment, per-limb, and per-patient basis. Given the small numbers in the per-limb and per-patient basis, Yates correction of 0.5 was applied. All statistical analysis was done using Microsoft Excel.
Results
A total of 24 patients (17 male and 7 female, mean age 64.9 years, range 55-80 years) with symptoms of peripheral vascular disease were recruited, following referral for routine contrast-enhanced peripheral MR angiography. Of the study group, the majority of patients had claudication (Rutherford 1-3), although two patients had rest pain (Rutherford 4) and one patient had tissue loss (Rutherford 5). The complete breakdown of the claudication patients was 3 with Rutherford 1, 12 patients with Rutherford 2, and 6 patients with Rutherford type 3 disease. Figure 2 shows typical representative images obtained for three example patients using the three different techniques. The phase-contrast velocity profiles are shown for comparison, to demonstrate that for each of these cases there is some pulsatility of flow in both legs, even though the flow profiles may differ substantially between them. Figure 3 shows the results for segment visibility out of a possible total of 864 segments for each technique. This demonstrates overall better visibility of segments using the VEL-FSD technique as compared to the ACC-FSD, although neither performed as well as the CE-MRA standard. Of the 256 segments (out of 864) graded as not visible or partially visible using ACC-FSD, 205 segments (80.0%), and of the 157 segments graded as not visible or partially visible using VEL-FSD, 75 segments (47.8%) were thought to be due to technique-related issues rather than due to occlusive pathology. Concordance between the two reviewers regarding whether a segment was not visible due to technique or pathology was 50% for the ACC-FSD, 36.2% for VEL-FSD, and 55.6% for CE-MRA.
Overall diagnostic confidence was rated as moderate or high in 98.5% of segments scored using CE-MRA, 79.9% using ACC-FSD, and 92.1% using VEL-FSD. Table 1 shows the diagnostic confidence of each method by segment. The sensitivity, specificity, PPV, and NPV of the two methods using CE-MRA as the gold standard and considering stenosis >50% as significant disease on a per-segment, per-limb, and per-patient basis is shown in Table 2 . McNemar's chi-squared test did not demonstrate significant differences in sensitivity for significant stenosis between the two techniques on a per-segment (P 5 1.00), per-limb (P 5 0.13), or perpatient (P 5 0.77) basis, although the per-limb results came closest to reaching significance.
The degree of venous contamination (Fig. 4) was scored as none in 96% of evaluated segments using CE-MRA as compared to 85.8% using ACC-FSD and 72.2% using VEL-FSD. The respective percentage scores for some venous contamination were 3.5%, 11.9%, and 23.3% and for significant venous contamination 0.5%, 2.3%, and 4.5%.
It was noted that in four cases the phase contrast flow profiles showed little or no flow pulsatility for one of the legs, and that this corresponded with a poor signal in acceleration-sensitized NCE-MRA for the corresponding leg. Two examples are shown in Fig. 5 .
Discussion
The aim of this study was to explore the use of novel NC-MRA techniques for the evaluation of the infregeniculate vessels in patients with PAD. The infrageniculate arteries pose a challenging imaging problem by conventional imaging modalities due to the small size of the vessels and the presence of calcification hampering assessment by CTA and DUS. Nevertheless, as techniques both by open surgery and in particular by endovascular means improve, stenoses and occlusions in these vessels that were once untreatable are now being routinely revascularized. The emergence of the angiosome concept in targeting revascularization 21 means accurate preprocedure imaging is key in planning intervention. Better MRA reconstruction algorithms recently have led to an improvement in spatial resolution and quality. 22, 23 In addition, a number of NCE-MRA techniques have also been described of which some are flow-independent 24 and others rely on the inherent properties of flowing blood. [25] [26] [27] Most of these studies have demonstrated technical feasibility, although real-world data in specific at-risk population groups such as diabetic patients remains limited. 28 Newer developments such as examinations performed at 3T hold promise for the future. 29, 30 This work assessed two recently developed flowdependent subtraction-based methods of performing NCE-MRA: the VEL-FSD technique, which has previously been demonstrated 15 to provide visibility of the infrageniculate vessels in patients with PAD, relies on the velocity of blood; and ACC-FSD, which relies on acceleration and has been shown to provide beneficial artery-vein separation in healthy controls. 16 This study compares the two methods when used for assessment of the infrageniculate vessels, with CE-MRA as a reference standard. We demonstrated that overall visualization of the various infrageniculate segments is reasonable with both techniques when compared to CE-MRA. The experienced reporters felt more comfortable in terms of diagnostic confidence using VEL-FSD rather than ACC-FSD. Overall, per-patient sensitivity to disease is high for both techniques, although the per-segment sensitivity is considerably lower. This is not entirely unsurprising given that multifocal disease is common in this patient cohort. Another contributory factor could be related to technique failure near the edge of the FOV, although previously similar reported issues with vessel visualization are less evident with the current version of the VEL-FSD method. As expected, the ACC-FSD technique is more resistant to venous contamination than VEL-FSD. Examination of the flow profiles measured by phasecontrast MRI helps us to better understand some of the strengths and weaknesses of these flow-dependent NCE-MRA techniques. These profiles were used to align the timing of the flow-suppression modules with peak arterial flow. However, in some cases the flow profiles for the two legs differed substantially and it was not possible to find a delay time which was optimal for both legs simultaneously and in these situations the chosen timings aimed to allow flow FIGURE 5: Example images from cases with little acceleration in one leg, and poor acceleration-sensitized NCE-MRA from the corresponding leg. Velocity-dependent, acceleration-dependent, and contrast-enhanced MRA images are shown, with the phasecontrast velocity profiles demonstrating the lack of pulsatility in one leg. suppression in both legs as far as possible. Future work might improve this by performing either the flowsensitization or the entire imaging process for the two legs separately in such cases, so that each leg could be optimized independently.
In many cases, the flow profiles measured in the below-knee arteries were adversely affected by proximal disease in the above-knee vessels. Flow velocities were typically much lower than those seen in healthy volunteers. The flow profiles also revealed that, in some cases, there was little or no flow acceleration in legs with severe upstream stenoses. In such cases the vessels were poorly depicted by the ACC-FSD sequence. Thus, ACC-FSD is probably unsuitable for reliable clinical imaging in such cases. However, ACC-FSD may still have other beneficial uses: it is useful in mapping normal anatomy without venous contamination, and in some clinical situations it may be a useful addition to VEL-FSD to aid the discrimination of arteries and veins, which are not always separated by this technique. Since both VEL-FSD and ACC-FSD may be acquired using the same bright-blood images, a combined VEL/ACC-FSD sequence could be acquired with a relatively small increase in the overall scan time.
Both NCE-MRA methods used bSSFP as the readout method. The sensitivity of this method to off-resonance effects does limit its success in the lower extremities, especially given the relatively poor homogeneity of the main magnetic field often achieved in this region. Such offresonance effects limit the useful maximum FOV of the method, which may account for the lower performance of these methods compared to CE-MRA. In the future, it is hoped that alternative readout strategies will improve the underlying image quality and thus improve diagnostic performance.
Other limitations of the study include the relatively small number of patients studied, although it is anticipated that as the techniques become more refined, in the future larger patient populations with specific at-risk subgroups such as diabetic patients will be studied. Both techniques described rely on assessment of flow in the popliteal and infrageniculate vessels; however, only the infrageniculate vessels were investigated here.
Ultimately, it may be the case that conventional imaging techniques (such as ultrasound or CT) may be employed for imaging of the larger ilio-femoral vessels with single-station below-knee NCE-MRA employed in situations where conventional techniques may not be optimal; for instance, in the obese patient or in those with calcified vessels. The infrageniculate region was chosen for analysis with the expectation that even better results would be achieved in the iliac or femoro-popliteal segments due to the larger size of the vessels. Another role for this technique could be in patients with mixed arterial and venous leg ulcers where rapid arterio-venous shunting can limit the use of CE-MRA due to venous contamination. Potentially, an algorithm whereby CE-MRA is employed in the supra-inguinal and femero-popliteal segments with NCE-MRA techniques below the knee could be considered.
Finally, CE-MRA was used as the reference standard, in line with most published studies in the literature. 31 It may be that digital subtraction angiography (DSA) is a more appropriate "gold standard" to compare with, although clearly there may be practical and ethical issues in performing such a comparison. Flow-dependent NCE-MRA techniques using acceleration and velocity flow sensitization may have diagnostic value in the assessment of patients with PAD. In this study comparing the initial diagnostic performance in such patients using both techniques, there was greater diagnostic confidence using the velocity sensitization approach (VEL-FSD) but at the expense of greater venous contamination.
